Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis

Interferon beta (IFN-β) and glatiramer acetate (GA) are the primary therapeutic immunomodulatory agents that interfere with relapsing-remitting multiple sclerosis (RRMS), and the most commonly-used drugs as well. Induction or aggravation of other immune-mediated diseases has been reported following...

Descripción completa

Detalles Bibliográficos
Autores principales: Baghbanian, Seyed Mohammad, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420690/
https://www.ncbi.nlm.nih.gov/pubmed/30886680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420690/
https://www.ncbi.nlm.nih.gov/pubmed/30886680

Ejemplares similares